The Biocidal Product Committee working group enables to anticipate the opinions that will be published on the assessment of active substance/ biocidal product type (AS/PT) combinations. The planning for the submissions of product authorisation dossiers is therefore established. The agenda of the BPC published on ECHA’s website presents different substances to assess for the years 2017 and 2018. These assessments will be validated during the plenary sessions, at the dates defined for each active substance.

Avancement de l’évaluation des substances actives biocides par le BPC

The BPC’s work programme

The active substances listed are those for which the competent authority of the assessment has confirmed to SECR (ECHA secretariat) that it was preparing the necessary documents for the assessment during the meetings planned in the programme.

The substances are presented in a table, next to the type of product in which it is found, the competent authority in charge of its assessment, if the substance is candidate to substitution according to the competent authority report, if the substance meets the exclusion criteria according to the CAR.

You can read through the BPC’s work programme on ECHA’s website.

The last opinions published concerned Margosa extract for PT 19 and Fludioxonil for PT 7, 9 and 10.

Reminder of the product-types considered:

source: ECHA

The 4 opinions adopted by the BPC

Margosa extract for PT 19

Context

Margosa extract is oil made from the cold press extraction of Azadirachta indica seeds with the help of carbon dioxide.

Use

Margosa extract is used to control harmful organisms (invertebrates such as fleas, vertebrates such as birds, fish, rodents), by repelling or attracting, including those that are used for human or veterinary hygiene either directly on the skin or indirectly in the environment of humans or animals.

Decision

Exposure risks for human health relating to a use against harmful organisms has been deemed “acceptable”.

Exposure risks for the environment required an additional risk assessment, based on tonnage, to take into account the unequal spatial and temporal distributions for surface water, sediment, and soil. These risks are deemed acceptables. As Margosa extract does not meet the criteria to be classified as a CMR (Carcinogenic, mutagenic and toxic to reproduction), PBT (Persistant, Bioaccumulative and Toxic), vPvB (very Persistant and very Bioaccumulative), endocrine disruptor or respiratory sensitizer, there have not been any concerns relating to its critical effects, or to the amount non-active isomers.

Its use is deemed safe for human health as well as for the environment. It is not considered as a candidate to substitution.

Fluodoxinol for PT 7,9 and 10

Context

Its real name, 4-(2,2-difluoro-1,3-benzodioxol-4-yl)-1H- pyrrole-3-carbonitrile was evaluated for PT 7,9 and 10. To learn more, go to ECHA’s website.

Use

Fluodoxinol is used:

  • for the preservation of films or coatings by the control of microbial deterioration or algal growth in order to protect the initial properties of the surface of materials or objects such as paints, plastics, sealants, wall adhesives, binders, papers, art works.
  • for the preservation of fibrous or polymerised materials, such as leather, rubber or paper or textile products by the control of microbiological deterioration. This product-type includes biocidal products which antagonise the settlement of micro-organisms on the surface of materials and therefore hamper or prevent the development of odour and/or offer other kinds of benefits.
  • for the preservation of masonry, composite materials, or other construction materials other than wood by the control of microbiological and algal attack.

Decision

(Valid for 3 product types: PT7, PT9, PT10)

Exposure risks for human health and the environment relating to a use against harmful organisms has been deemed “acceptable”. Its use has been deemed safe for human health and for the environment. Fluodoxinol does not meet the criteria to be classified as a CMR (Carcinogenic, mutagenic and toxic to reproduction), PBT (Persistant, Bioaccumulative and Toxic), vPvB (very Persistant and very Bioaccumulative), endocrine disruptor or respiratory sensitizer. There have not been any concerns relating to its critical effects, or to the amount non-active isomers.

Substances under evaluation

Cypermethrin, used for the control of arthropods (such as insects, arachnids and crustaceans PT 18)), as well as MIT (5-chloro-2-methyl-2H-isothiazol-3-un) used as a slimicide (PT12) are under evaluation by the committee.

You wish to learn more?

EcoMundo’s experts help you:

  • Establish a global strategy for your dossier creation.
  • Identify the size of your company and confirm it with the Agency to receive a discount for SMEs
  • Create the « Data gap » from the tox and ecotox data to provide (read-across strategy, QSAR…)
  • With the scientific argumentation
  • Collect relevant data: analytical, efficacy, toxicology, ecotoxicology, residue anaysis, etc.
  • Fill out the dossier in IUCLID 6 format and generate the dossier
  • Submit the dossier via R4BP

You can also call us on +33 (0)1 83 64 20 54 for ’Europe or on + 1 (778) 231-1607 for North America or by email at [email protected]

Articles liés

vignette blog

How to conduct your biocidal risk assessment?

Risk assessments are generally required for authorisation applications. These dossiers are necessary to ... Learn more

vignette blog

Approved suppliers: Be ready !

On September 1st, 2015, Article 95 of the Biocidal Products Regulations (BPR) establishes the obligation for manufacturers ... Learn more

vignette blog

Biocidal registration services: Why call on a service provider?

The Biocides Regulation 528/2012 (BPR) brings you to change your approaches from manufacturing to marketing your product. Many parameters ... Lire la suite

  Post a comment
x

Post a comment

Our teams are available to answer any and all enquiries you might have.

Filtered HTML

The comment language code.
 

We use cookies to ensure that you have the best possible browsing experience on our website. Learn more